Physician profile
Christopher Carl Phillips
NPI 1205940483
$37,109.06
in general payments reported to CMS, 2019-2025
16 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,615 · 2020: $634 · 2021: $411 · 2022: $6,251 · 2023: $22K · 2024: $4,602 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $1,302 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,875.00 |
| Food and Beverage | $1,302.23 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $32,942.95 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Abbott Laboratories | $2,612.93 | 2019-2021 | |
| Edwards Lifesciences Corporation | $379.79 | 2019-2025 | Mitris Resilia Mitral Valve |
| Zimmer Biomet Holdings, INC. | $297.32 | 2021-2025 | |
| Abiomed | $263.56 | 2020-2023 | Impella |
| Getinge USA Sales, LLC | $155.06 | 2020-2025 | Vasoview Hemopro 2 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $138.58 | 2019-2024 | Lifevest |
| Corcym INC | $132.58 | 2023-2024 | Perceval |
| Pinnacle, INC | $34.86 | 2024 | |
| Kls-Martin L.P. | $27.69 | 2019 | |
| Bard Peripheral Vascular, INC. | $26.88 | 2019 | |
| Lsi Solutions INC | $26.28 | 2019 | |
| Kci USA, INC. | $20.50 | 2020 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Boston Scientific Corporation | $15.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $14.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.